OOIR: Observatory of International Research

Papers

(The median citation count of Journal of Neurovirology is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-10-01 to 2025-10-01.)

Article	Citations
Possible role of CNS microRNAs in Human Mpox virus encephalitis—a mini-review	56
Successful treatment of HIV-associated progressive multifocal leukoencephalopathy (PML) with mirtazapine, mefloquine, and IVIG combination therapy: a case report	23
Zika virus infection of retinal cells and the developing mouse eye induces host responses that contrasts to the brain and dengue virus infection	22
Cognitive function and impact on driving after SARS-COV-2 infection in a man with long-standing HIV infection: a case report	16
Longitudinal, virological, and serological assessment of hospitalized COVID-19 patients	16
HIV associated motor neuron disease (MND): A case series with systematic review of literature	16
Sex-specific mitochondrial DNA changes in neuron-derived extracellular vesicles of African American adults: impact of HIV infection and smoking	16
Progressive multifocal leukoencephalopathy in sarcoidosis successfully treated with pembrolizumab	16
Combined effects of older age and HIV disease on changes in everyday functioning over one year	16
Serum of COVID-19 patients changes neuroinflammation and mitochondrial homeostasis markers in hippocampus of aged rats	15
Serum mir-142-3p release in children with viral encephalitis and its relationship with nerve injury and inflammatory response	15
Progressive multifocal leukoencephalopathy, advanced ductal breast carcinoma, systemic sclerosis, and checkpoint inhibitors: a therapeutic dilemma	15
Correction: The presence of human polyomavirus JC (JCPyV) in pediatric brain tumors: a plausible trigger in Wnt/β-catenin pathway	15
Time since HIV diagnosis is linked to amnestic mild cognitive impairment (MCI) in older adults with HIV	14
A case of progressive multifocal leukoencephalopathy with hypogammaglobulinemia and a TCF3 mutation	14
Varicella-zoster virus meningitis coincident with bacteremia caused by liver abscess: a case report	13
SARS-CoV-2–associated Guillain–Barre syndrome requires extensive pre- and post-mortem examinations	13
HIV-1 and methamphetamine alter galectins -1, -3, and -9 in human monocyte-derived macrophages	12
Long-term survival from progressive multifocal leukoencephalopathy in living-donor liver transplant recipient with preformed donor-specific antibody	12
Upregulation of microRNAs correlates with downregulation of HERV-K expression in Parkinson’s disease	11
Effect of coinfections on neurocognitive functioning among people with clade C HIV infection in Zambia	11
Seropositivity and reactivations of HSV-1, but not of HSV-2 nor VZV, associate with altered blood–brain barrier, beta amyloid, and tau proteins in people living with HIV	11
Neurological manifestations of COVID-19 in pregnancy: a cross-sectional study	11
SARS-CoV-2-associated haemorrhagic encephalitis mimicking Herpes encephalitis	11
Incidence of tick-borne encephalitis (TBE) in the pediatric population at the University Hospitals of Strasbourg (HUS) and characterization of confirmed cases	10

Cerebrospinal Fluid Biomarkers of Symptomatic Neurosyphilis in People With HIV Compared with Uninfected Individuals	10
A case of ischemic stroke secondary to varicella-zoster virus meningoencephalitis	9
HIV-1 Tat drives the Fabp4/NF-κB feedback loop in microglia to mediate inflammatory response and neuronal apoptosis	9
Detection of human herpesviruses in cerebrospinal fluids collected from patients suspected of neuroinfectious diseases	9
Fentanyl dysregulates neuroinflammation and disrupts blood-brain barrier integrity in HIV-1 Tat transgenic mice	9
Low incidence of advanced neurological burden but high incidence of age-related conditions that are dementia risk factors in aging people living with HIV: a data-linkage 10-year follow-up study	9
Genetic polymorphisms in innate immunity genes influence predisposition to tick-borne encephalitis	9
A human-derived 3D brain organoid model to study JC virus infection	9
Designing a cellular MicroRNA-based approach to silence bat-borne Nipah virus genes	8
Simian varicella virus infection and reactivation in rhesus macaques trigger cytokine and Aβ40/42 alterations in serum and cerebrospinal fluid	8
Cerebral and spinal cord changes observed through magnetic resonance imaging in patients with HTLV-1–associated myelopathy/tropical spastic paraparesis: a systematic review	8
Increased expression of PD-1 in CD8 + CD3 + T cells correlates with EBV viral load in MS patients	7
Refining the risk of HTLV-1-associated myelopathy in people living with HTLV-1: identification of a HAM-like phenotype in a proportion of asymptomatic carriers	7
HIV-associated multiple intracranial aneurysms and stroke in an adult patient: successful treatment with a combination of glucocorticoid and antiviral agents	7
In vitro characterization of the antiviral activity of Bat Interferon-Induced protein with tetratricopeptide repeats 5 (bat IFIT5) against bat-associated rabies virus	7
Influence of plasma exosomes from women living with HIV Stratified by HAND on monocyte subpopulations from healthy women without HIV	7
Progressive multifocal leukoencephalopathy and peripheral neuropathy in a patient with Good’s syndrome	7
A rare kind of Guillain-Barre syndrome triggered by acute hepatitis A infection in a pediatric patient: a case report and review of literature	6
Infection of human microglial cell line CHME-3 to study neuropathogenesis of chikungunya virus	6
Evolving etiologies, comorbidities, survival, and costs of care in adult encephalitis	6
Correction to: Antiretroviral drugs induce oxidative stress and neuronal damage in the central nervous system	6
Cognitive deficits in HTLV-1 patients	6
Expression in skin biopsies supports genetic evidence linking CAMKK2, P2X7R and P2X4R with HIV-associated sensory neuropathy	6
Comment on “Limited HIV-associated neuropathologies and lack of immune activation in sub-saharan African individuals with late-stage subtype C HIV-1 infection”	6
Herpesviruses, polyomaviruses, parvoviruses, papillomaviruses, and anelloviruses in vestibular schwannoma	6
Differential effects of fentanyl compared to morphine on neuroinflammatory signaling in the brain in EcoHIV-infected mice	6
Limited evidence for a moderating effect of HIV status on brain age in heavy episodic drinkers	6
Cerebral vasculitis caused by Talaromyces marneffei and Aspergillus niger in a HIV-positive patient: a case report and literature review	5
Stroke risk after varicella-zoster virus infection: a systematic review and meta-analysis	5
Evaluation of the effects of the Zika Virus-Immunoglobulin G+ complex on murine microglial cells	5
Catastrophic tumefactive acute disseminated encephalomyelitis in patient with dengue virus: a case report	5
Generating fair, reliable, and accurate neuropsychological test norms for people with HIV in a low- or middle-income country	5
Detection of human neurotropic JCPyV DNA sequence in pediatric anaplastic xanthoastrocytoma	5
Innate immune memory in chronic HIV and HIV-associated neurocognitive disorders (HAND): potential mechanisms and clinical implications	5
Maintaining the battle against vaccine-preventable neurological diseases in the United States	5
Characterizing Epstein-Barr virus infection of the central nervous system in Zambian adults living with HIV	5
Metformin promotes PEN2 expression to attenuate microglia-mediated neurotoxicity induced by HIV-1 Tat	5
Myelin regulatory factor is a target of individual and interactive effects of HIV-1 Tat and morphine in the striatum and pre-frontal cortex	5
Rapid-progressing progressive multifocal leukoencephalopathy in two patients newly diagnosed with HIV: case series and review of literature	5
Implications of vascular depression for successful cognitive aging in HIV Disease	5
Cytomegalovirus infection induces Alzheimer’s disease-associated alterations in tau	5
Cortico-striatal networking deficits associated with advanced HIV disease and cocaine use	4
A pilot study of cognition and creativity among persons with HIV disease referred for neuropsychological evaluation	4
Response to “a fatal case of Guillain-Barré syndrome after infection with COVID-19”	4
Monkeypox virus replication underlying circadian rhythm networks	4
Neuroimaging and immunological features of neurocognitive function related to substance use in people with HIV	4
Higher buccal mitochondrial DNA and mitochondrial common deletion number are associated with markers of neurodegeneration and inflammation in cerebrospinal fluid	4
The incidence of symptomatic CSF viral escape in patients on antiretroviral therapy in western India: a retrospective cohort study	4
Differential expression of cellular prion protein (PrPC) in mouse hepatitis virus induced neuroinflammation	4
T-lymphocyte activation markers in patients with HIV-1-associated neurocognitive disorder	4

Mapping ACE2 and TMPRSS2 co-expression in human brain tissue: implications for SARS-CoV-2 neurological manifestations	4
Cooperative interactions between neurotrophin receptors and CXCR4 regulate macrophage phenotype and susceptibility to activation by HIV	4
Systematic post-mortem analysis of brain tissue from an HIV-1 subtype C viremic decedent revealed a paucity of infection and pathology	4
HSV-1 latency-associated transcript miR-H3 and miR-H4 target STXBP1 and GABBR2 genes	4
The relationship between vascular endothelial growth factor (VEGF) and amnestic mild cognitive impairment among older adults living with HIV	4
Encephalomyelitis in a patient with monkeypox: an unusual complication	4
Plasma extracellular vesicles and cell-free mitochondrial DNA are associated with cognitive dysfunction in treated older adults with HIV	4
The synergistic effect of insomnia and depression on risk of herpes zoster	4
Substance use moderates relationships between apolipoprotein E genotype, hepatitis C, cognition, and depression in Miami Adult Studies on HIV (MASH) participants	3
Altered white matter microstructure and neurocognitive function of HIV-infected patients with low nadir CD4	3
Central nervous system reactivation of herpesviridae family in patients with COVID-19	3
Sex differences in cognitive function among people with HIV-1 clade C infection in Northern India	3
Single nucleotide polymorphisms in aquaporin-4 associate with cognitive impairment status in people with HIV	3
Artery of Percheron infarction associated with COVID-19 in the young adult	3
High glucose potentiates Zika virus induced-astroglial dysfunctions	3
Differences in neuroinflammation in people who started antiretroviral treatment during primary versus chronic HIV infection: an 18kDa Translocator protein (TSPO) positron emission tomography (PET) stu	3
SARS-CoV and SARS-CoV-2 display limited neuronal infection and lack the ability to transmit within synaptically connected axons in stem cell–derived human neurons	3
Neuropsychological profile of patients with infectious disease: characterization and comparison of patients with HIV, HTLV, and HCV	3
Neuropsychiatric disorders in the course to SARS-CoV-2 virus infection, including biological pathomechanisms, psychosocial factors and long COVID-19 associated with “brain fog”	3
Post-COVID-19 olfactory dysfunction: carbamazepine as a treatment option in a series of cases	3
Monitoring of HTLV-1-associated diseases by proviral load quantification using multiplex real-time PCR	3
The synthetic opioid fentanyl increases HIV replication and chemokine co-receptor expression in vitro	3
Acute cerebellitis following COVID-19 infection associated with autoantibodies to glutamate receptors: a case report	3
Meta-analysis of the serum/plasma proteome identifies significant associations between COVID-19 with Alzheimer’s/Parkinson’s diseases	3
Amebic infections of the central nervous system	3
Correction to: Plasma extracellular vesicles and cell-free mitochondrial DNA are associated with cognitive dysfunction in treated older adults with HIV	3
Reactivation of varicella zoster virus following trigeminal schwannoma resection	3
Regulation of voltage-gated sodium channels by TNF-α during herpes simplex virus latency establishment	3
Notes from guest editor Dr. Fatah Kashanchi	3
Is there a connection between neurocognitive profile in treatment naïve non-cirrhotic HCV patients and level of systemic inflammation?	3
Relationship of the balloon analog risk task to neurocognitive impairment differs by HIV serostatus and history of major depressive disorder	3
Role of inflammatory cytokine burst in neuro-invasion of Japanese Encephalitis virus infection: an immunotherapeutic approaches	3
The evaluation expression of non-coding RNAs in response to HSV-G47∆ oncolytic virus infection in glioblastoma multiforme cancer stem cells	3
A viral attack on brain tumors: the potential of oncolytic virus therapy	3
Difference in the neurocognitive functions of WLWH and MLWH in an Italian cohort of people living with HIV	3
Atypical disseminated herpes zoster infections in patients with demyelinating disease treated with dimethyl fumarate	3
Compassionate-use pocapavir and immunoglobulin therapy for treatment of rituximab-associated enterovirus meningoencephalitis	3
A frantic confusion: beyond rabies and anti-N-methyl-D-aspartate encephalitis	3
Progressive multifocal leukoencephalopathy: a retrospective study of the last 12 years in a tertiary-care hospital	3
Blood and cerebrospinal fluid biomarker changes in patients with HIV-associated neurocognitive impairment treated with lithium: analysis from a randomised placebo-controlled trial	2
Norovirus-associated neurological manifestations: summarizing the evidence	2
CSF markers of AD-related pathology relate specifically to memory impairment in older people with HIV: a pilot study	2
COVID-19-associated necrotizing encephalopathy presenting without active respiratory symptoms: a case report with histopathology	2
HIV viremia contributes to neurocognitive impairments in persons who use cocaine	2
Assessing cognitive impairment in HIV-infected: a comparative study of international HIV Dementia Scale, HIV Dementia Scale Italian version and Montreal cognitive assessment in clinical practice	2
Immune-mediated cerebellitis following SARS-CoV-2 infection—a case report and review of the literature	2
Persistent accelerated epigenetic ageing in a longitudinal cohort of vertically infected HIV-positive adolescents	2
Human immunodeficiency virus-1 Tat exerts its neurotoxic effects by downregulating Sonic hedgehog signaling	2
Additive cortical gray matter deficits in people living with HIV who use cocaine	2
Risk factors of herpes simplex virus reactivation after surgery for primary trigeminal neuralgia	2
The presence of human polyomavirus JC (JCPyV) in pediatric brain tumors: a plausible trigger in Wnt/β-catenin pathway	2
Cognitive performance in a South African cohort of people with HIV and comorbid major depressive disorder	2
Neurological manifestations of coronavirus infections, before and after COVID-19: a review of animal studies	2
The association between benzodiazepine use and greater risk of neurocognitive impairment is moderated by medical burden in people with HIV	2
Momordica charantia phytoconstituents can inhibit human T-lymphotropic virus type-1 (HTLV-1) infectivity in vitro and in vivo	2
Cerebrospinal fluid CD14++CD16+ monocytes in HIV-1 subtype C compared with subtype B	2
RNA-Seq time-course analysis of neural precursor cell transcriptome in response to herpes simplex Virus-1 infection	2
Multiple demyelinating sensory and motor mononeuropathy associated with COVID-19: a case report	2
Correction: Performance of the national institute of infectious diseases disability scale in HTLV-1-associated myelopathy/tropical spastic paraparesis	2
Caffeine upregulates SIRT3 expression to ameliorate astrocytes-mediated HIV-1 Tat neurotoxicity via suppression of EGR1 signaling pathway	2
Clinical use of steroids in viral central nervous system (CNS) infections: three challenging cases	2
Multi-functional auto-fluorescent nanogels for theranostics	2
Sequential treatment of progressive multifocal leukoencephalopathy with intravenous immunoglobulins and pembrolizumab	2
Disruption of blood–brain barrier: effects of HIV Tat on brain microvascular endothelial cells and tight junction proteins	2
Immune response to COVID-19 vaccines among people living with human T-cell lymphotropic virus type 1 infection: a retrospective cohort study from Iran	2
Susac syndrome complicating a SARS-CoV-2 infection	2
Cognitive dysfunction following COVID-19 infection	2
Detection of disease-associated microglia among various microglia phenotypes induced by West Nile virus infection in mice	2
A case of trigeminal neuralgia developing after a COVID-19 vaccination	2
Induced expression of rabies glycoprotein in the dorsal hippocampus enhances hippocampal dependent memory in a rat model of Alzheimer’s disease	2
HIV peripheral neuropathy‐related degeneration of white matter tracts to sensorimotor cortex	2
iPSC-derived three-dimensional brain organoid models and neurotropic viral infections	2
Changes in cerebral function parameters in persons with HIV with symptoms of insomnia switching from dolutegravir- to bictegravir-based antiretroviral therapy	2